11/06/2024
11:14 AM | Iradimed (Subject)
VUOTO ANTHONY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
3:15 PM | Iradimed (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
7:00 AM | Iradimed (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Iradimed (Subject)
| Form SC 13G | |
10/15/2024
4:45 PM | Iradimed (Issuer)
Scharen-Guivel Hilda Frederique (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
3:30 PM | Iradimed (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
7:30 AM | Iradimed (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
06/07/2024
7:30 AM | Iradimed (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
4:15 PM | ALLEN MONTY K (Reporting)
Iradimed (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
9:40 AM | ALLEN MONTY K (Reporting)
Iradimed (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
7:30 AM | Iradimed (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
8:16 AM | Iradimed (Filer)
| Form ARS | |
05/08/2024
11:15 PM | Iradimed (Filer)
| Form EFFECT | |
05/02/2024
7:30 AM | Iradimed (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
7:30 AM | Iradimed (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2024
11:03 AM | Iradimed (Subject)
Nine Ten Capital Management LLC (Filed by)
| Form SC 13G/A | |
02/08/2024
7:05 AM | Iradimed (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
8:44 AM | Iradimed (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
| Form SC 13G/A | |
12/27/2023
5:30 PM | Iradimed (Issuer)
Susi Roger E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
4:15 PM | Iradimed (Issuer)
Susi Roger E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
7:05 PM | HAWKINS JAMES B (Reporting)
Iradimed (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
3:34 PM | HAWKINS JAMES B (Reporting)
Iradimed (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
4:15 PM | HAWKINS JAMES B (Reporting)
Iradimed (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
4:30 PM | HAWKINS JAMES B (Reporting)
Iradimed (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023
5:00 PM | HAWKINS JAMES B (Reporting)
Iradimed (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
5:00 PM | ALLEN MONTY K (Reporting)
Iradimed (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
5:00 PM | Iradimed (Issuer)
VUOTO ANTHONY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
5:00 PM | Iradimed (Issuer)
Scharen-Guivel Hilda Frederique (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
5:00 PM | GLENN JOHN (Reporting)
Iradimed (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
3:05 PM | Iradimed (Issuer)
Susi Roger E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
3:30 PM | HAWKINS JAMES B (Reporting)
Iradimed (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
7:00 PM | HAWKINS JAMES B (Reporting)
Iradimed (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023
7:32 PM | HAWKINS JAMES B (Reporting)
Iradimed (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023
3:05 PM | Iradimed (Issuer)
Susi Roger E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
